In inpatients with COVID-19 who need supplemental oxygen, lenzilumab increased ventilation-free survival. Mariano VJ, Mylonakis E. Ann Intern Med 2022 Apr 5. doi: 10.7326/J22-0019.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mariano VJ, Mylonakis E. In inpatients with COVID-19 who need supplemental oxygen, lenzilumab increased ventilation-free survival. Ann Intern Med 2022 Apr 5. doi: 10.7326/J22-0019.
PMID: 35377717